Arcline Sells Medical Manufacturing Technologies to Perimeter Solutions
Arcline Investment Management, a private equity firm focused on growth, recently made headlines with its decision to sell its portfolio company Medical Manufacturing Technologies (MMT) to Perimeter Solutions, Inc for a substantial $685 million. This strategic move reinforces Arcline's commitment to expanding its influence and success in the medical device manufacturing sector.
About Medical Manufacturing Technologies
Medical Manufacturing Technologies, located in Charlotte, North Carolina, stands as a formidable player in the global market for medical device manufacturing. MMT specializes in delivering comprehensive manufacturing solutions tailored for automated and process-driven environments. The company caters to an expansive customer base exceeding 1,000 clients, which includes many renowned original equipment manufacturers (OEMs) and contract developers and manufacturers (CDMOs). MMT's expertise is particularly evident in its production capabilities, which encompass a variety of complex devices, such as catheters, guidewires, stents, and microcoils, all of which are fundamental in the medical field.
The Growth Journey Under Arcline
Since its acquisition of MMT in 2020, Arcline has applied a well-structured growth strategy that has enhanced the scale and efficiency of MMT's operations. The firm has not only increased the company's revenue and EBITDA but has also been instrumental in executing 13 targeted acquisitions. These acquisitions have broadened MMT's capabilities, allowing them to introduce innovative automation solutions and specialty manufacturing services. Such enhancements are pivotal in optimizing complex production processes, ensuring that clients receive the highest quality standards.
Leadership and Team Appreciation
Arcline has expressed sincere gratitude towards the leadership at MMT, particularly Chief Executive Officer Robbie Atkinson, and the dedicated MMT team. Their collaboration and commitment have been crucial in positioning MMT as a reliable partner for manufacturers operating in precision-driven and highly regulated markets.
Expectations and Future Transactions
With the expected closure of this transaction in the first quarter of 2026, pending necessary regulatory approvals and customary closing conditions, the industry is keenly watching how this will shape the market landscape. The transaction illustrates Arcline's dynamic approach to building value and creating tailored solutions in the medical manufacturing space.
Advisory Support during the Transaction
For this significant transaction, Arcline has enlisted the expertise of financial advisors William Blair and Houlihan Lokey. Legal counsel has been provided by Kirkland & Ellis LLP and Fredrikson & Byron P.A., ensuring that all facets of the deal are handled with utmost professional integrity and expertise.
About Arcline Investment Management
Arcline Investment Management is recognized for its growth-oriented approach within the private equity sphere, managing over $20 billion in assets. The firm strives to develop market-leading, non-disruptible platforms in various industrial sectors, aimed at achieving consistent growth over decades. Their robust strategy not only fosters innovation but also promotes sustainability in the companies they nurture.
Contact Information
For media inquiries, please contact Arcline via their website or use the provided contact details. Further information about their initiatives can be found by browsing their official website, which serves as a resource for any interested stakeholders.
Frequently Asked Questions
What is the value of the transaction between Arcline and Perimeter Solutions?
The transaction is valued at $685 million.
Who are the financial advisors for this deal?
William Blair and Houlihan Lokey are serving as financial advisors for Arcline regarding the sale.
What services does Medical Manufacturing Technologies provide?
MMT is a leader in medical device manufacturing solutions, offering automated and process-driven manufacturing for complex medical devices.
What has been the impact of Arcline's ownership of MMT since 2020?
Arcline has successfully grown MMT's revenue and EBITDA, executing numerous acquisitions that expanded its capabilities.
When is the expected closing date for the transaction?
The expected closing date is in the first quarter of 2026, subject to regulatory approvals.
